TRENDS IN THE UTILIZATION OF IMMUNOGLOBULIN PRODUCTS AT OUR INSTITUTION: IMPACT ON ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION OUTCOMES
Authors
- Yoshiki Okuyama
- Mayumi Shoji
- Keigo Setoguchi
- Tatsu Shimoyama
- Noriko Doki (ORCID: https://orcid.org/0000-0002-8661-3179)
- Kae Sakuma
- Rei Watanabe (ORCID: https://orcid.org/0000-0001-8254-9176)
- Shuhei Kurosawa (ORCID: https://orcid.org/0000-0001-6426-6770)
- Aya Nishizawa (ORCID: https://orcid.org/0000-0002-0723-2926)
- Sayuri Ishibashi
- Misako Nishimura (ORCID: https://orcid.org/0000-0001-9553-2576)
- Ryosuke Suzuki (ORCID: https://orcid.org/0000-0003-0296-8843)
- Moemi Ishiwada
- Ryoko Iimura
- Kiyomi Narishima
- Yunoka Honma
- Yoshiharu Miura
- Kyoko Haraguchi
- Akihito Ohta
- Fuyuko Kawai
Institutions
- Tokyo Metropolitan Komagome Hospital (JP)
Publication Details
- Journal
- Japanese Journal of Transfusion and Cell Therapy
- Published
- 2025-08-25
- DOI
- https://doi.org/10.3925/jjtc.71.662
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00